Annual Long Term Debt
$1.60 M
+$196.00 K+13.92%
31 December 2023
Summary:
Theriva Biologics annual long term debt is currently $1.60 million, with the most recent change of +$196.00 thousand (+13.92%) on 31 December 2023. During the last 3 years, it has risen by +$1.42 million (+762.37%). TOVX annual long term debt is now -84.72% below its all-time high of $10.50 million, reached on 01 December 2002.TOVX Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Debt
$1.13 M
-$122.00 K-9.72%
01 September 2024
Summary:
Theriva Biologics quarterly long term debt is currently $1.13 million, with the most recent change of -$122.00 thousand (-9.72%) on 01 September 2024. Over the past year, it has dropped by -$563.00 thousand (-33.20%). TOVX quarterly long term debt is now -90.15% below its all-time high of $11.50 million, reached on 01 June 2002.TOVX Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TOVX Long Term Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +13.9% | -33.2% |
| 3 y3 years | +762.4% | -19.2% |
| 5 y5 years | +239.1% | +139.5% |
TOVX Long Term Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +762.4% | -42.3% | at low |
| 5 y | 5 years | at high | +762.4% | -42.3% | +949.1% |
| alltime | all time | -84.7% | -90.2% |
Theriva Biologics Long Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $1.13 M(-9.7%) |
| June 2024 | - | $1.25 M(-13.9%) |
| Mar 2024 | - | $1.46 M(-9.1%) |
| Dec 2023 | $1.60 M(+13.9%) | $1.60 M(-5.4%) |
| Sept 2023 | - | $1.70 M(-7.7%) |
| June 2023 | - | $1.84 M(-6.4%) |
| Mar 2023 | - | $1.96 M(+39.3%) |
| Dec 2022 | $1.41 M(+0.4%) | $1.41 M(-2.6%) |
| Sept 2022 | - | $1.45 M(-4.5%) |
| June 2022 | - | $1.51 M(-4.2%) |
| Mar 2022 | - | $1.58 M(+12.6%) |
| Dec 2021 | $1.40 M(+654.3%) | - |
| Dec 2021 | - | $1.40 M(+0.1%) |
| Sept 2021 | - | $1.40 M(-1.8%) |
| June 2021 | - | $1.43 M(+1220.4%) |
| Mar 2021 | - | $108.00 K(-41.9%) |
| Dec 2020 | $186.00 K(-60.7%) | $186.00 K(-28.7%) |
| Sept 2020 | - | $261.00 K(-21.9%) |
| June 2020 | - | $334.00 K(-17.5%) |
| Mar 2020 | - | $405.00 K(-14.4%) |
| Dec 2019 | $473.00 K(>+9900.0%) | $473.00 K(-12.2%) |
| Sept 2019 | - | $539.00 K(-10.3%) |
| June 2019 | - | $601.00 K(-9.2%) |
| Mar 2019 | - | $662.00 K(>+9900.0%) |
| Dec 2018 | $0.00 | $0.00(-100.0%) |
| Sept 2010 | - | $1900.00(-55.8%) |
| June 2010 | - | $4300.00(-53.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2010 | - | $9200.00(-28.1%) |
| Dec 2009 | $12.80 K(>+9900.0%) | $12.80 K(>+9900.0%) |
| Dec 2008 | $0.00(-100.0%) | $0.00(-100.0%) |
| Sept 2007 | - | $600.00 K(+71.4%) |
| June 2007 | - | $350.00 K(-12.5%) |
| Mar 2007 | - | $400.00 K(-96.2%) |
| Mar 2003 | - | $10.50 M(0.0%) |
| Dec 2002 | $10.50 M(+110.0%) | $10.50 M(-8.7%) |
| Sept 2002 | - | $11.50 M(0.0%) |
| June 2002 | - | $11.50 M(+15.0%) |
| Mar 2002 | - | $10.00 M(+100.0%) |
| Dec 2001 | $5.00 M(+150.0%) | $5.00 M(+66.7%) |
| Sept 2001 | - | $3.00 M(+50.0%) |
| June 2001 | - | $2.00 M(0.0%) |
| Mar 2001 | - | $2.00 M(0.0%) |
| Dec 2000 | $2.00 M(0.0%) | $2.00 M(0.0%) |
| Sept 2000 | - | $2.00 M(0.0%) |
| June 2000 | - | $2.00 M(0.0%) |
| Mar 2000 | - | $2.00 M(0.0%) |
| Dec 1999 | $2.00 M(+100.0%) | $2.00 M(+33.3%) |
| June 1999 | - | $1.50 M(0.0%) |
| Mar 1999 | - | $1.50 M(+50.0%) |
| Dec 1998 | $1.00 M(-37.5%) | $1.00 M(+100.0%) |
| Sept 1998 | - | $500.00 K(-44.4%) |
| Mar 1998 | - | $900.00 K(-43.8%) |
| Dec 1997 | $1.60 M | $1.60 M(-11.1%) |
| Sept 1997 | - | $1.80 M |
FAQ
- What is Theriva Biologics annual long term debt?
- What is the all time high annual long term debt for Theriva Biologics?
- What is Theriva Biologics annual long term debt year-on-year change?
- What is Theriva Biologics quarterly long term debt?
- What is the all time high quarterly long term debt for Theriva Biologics?
- What is Theriva Biologics quarterly long term debt year-on-year change?
What is Theriva Biologics annual long term debt?
The current annual long term debt of TOVX is $1.60 M
What is the all time high annual long term debt for Theriva Biologics?
Theriva Biologics all-time high annual long term debt is $10.50 M
What is Theriva Biologics annual long term debt year-on-year change?
Over the past year, TOVX annual long term debt has changed by +$196.00 K (+13.92%)
What is Theriva Biologics quarterly long term debt?
The current quarterly long term debt of TOVX is $1.13 M
What is the all time high quarterly long term debt for Theriva Biologics?
Theriva Biologics all-time high quarterly long term debt is $11.50 M
What is Theriva Biologics quarterly long term debt year-on-year change?
Over the past year, TOVX quarterly long term debt has changed by -$563.00 K (-33.20%)